Section on Clinical, Behavioral and Outcomes Research, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.
Department of Medicine, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
BMJ Open Diabetes Res Care. 2019 Jul 29;7(1):e000659. doi: 10.1136/bmjdrc-2019-000659. eCollection 2019.
We evaluated the relationship between frequency of self-monitoring of blood glucose (SMBG) and body weight, A1C, and cardiovascular risk factors in patients with type 2 diabetes (T2D) and obesity enrolled in a 12-week intensive multidisciplinary weight management (IMWM) program.
We conducted a retrospective analysis of 42 patients who electronically uploaded their SMBG data over 12 weeks of an IMWM program and divided them into tertiles based on their average frequency of SMBG per day. Mean (range) SMBG frequencies were 2.3 (1.1-2.9) times/day, 3.4 (3-3.9) times/day, and 5 (4-7.7) times/day in the lowest, middle, and highest tertiles, respectively. Anthropometric and metabolic parameters were measured at baseline and after 12 weeks of intervention.
Participants in the highest tertile achieved a median change (IQR) in body weight of -10.4 kg (-7.6 to -14.4 kg) compared with -8.3 kg (-5.2 to -12.2 kg), and -6.9 kg (-4.2 to -8.9 kg) in the middle and lowest tertiles, respectively (p=0.018 for trend). Participants in the highest tertile had a median change (IQR) in A1C of -1.25% (-0.6 to -3.1%) compared with -0.8% (-0.3% to -2%) and -0.5% (-0.2% to -1.2%) in the middle and lowest tertiles, respectively (p=0.048 for trend). The association between change in body weight and SMBG frequency remained significant after adjusting for age, sex, baseline body mass index, diabetes duration, and use of insulin therapy.
Increased frequency of SMBG during IMWM is associated with significantly better weight loss and improvement of A1C in patients with T2D and obesity. These findings may suggest future clinical recommendations aimed at increasing SMBG frequency to achieve the most favorable outcomes.
我们评估了自我监测血糖(SMBG)的频率与 2 型糖尿病(T2D)和肥胖患者的体重、A1C 和心血管危险因素之间的关系,这些患者参加了为期 12 周的强化多学科体重管理(IMWM)计划。
我们对参加为期 12 周 IMWM 计划的 42 名患者进行了回顾性分析,他们通过电子方式上传了 12 周的 SMBG 数据,并根据他们每天平均 SMBG 的频率将其分为三分位。最低、中、高三分位的平均(范围)SMBG 频率分别为 2.3(1.1-2.9)次/天、3.4(3-3.9)次/天和 5(4-7.7)次/天。在干预 12 周后测量了人体测量和代谢参数。
最高三分位组的参与者体重中位数(IQR)变化为-10.4kg(-7.6 至-14.4kg),而中三分位组和最低三分位组分别为-8.3kg(-5.2 至-12.2kg)和-6.9kg(-4.2 至-8.9kg)(趋势 p=0.018)。最高三分位组的参与者 A1C 中位数(IQR)变化为-1.25%(-0.6 至-3.1%),而中三分位组和最低三分位组分别为-0.8%(-0.3%至-2%)和-0.5%(-0.2%至-1.2%)(趋势 p=0.048)。调整年龄、性别、基线体重指数、糖尿病病程和胰岛素治疗后,体重变化与 SMBG 频率之间的关联仍然显著。
在 IMWM 期间增加 SMBG 的频率与 T2D 和肥胖患者的体重明显减轻和 A1C 改善相关。这些发现可能表明未来的临床建议旨在增加 SMBG 的频率,以实现最有利的结果。